62 results
8-K
EX-99.1
ORIC
ORIC Pharmaceuticals Inc
6 May 24
ORIC Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Updates
4:10pm
expects will be sufficient to fund its operating plan into late 2026.
R&D Expenses: Research and development (R&D) expenses were $22.0 million … expenses:
Research and development
General and administrative
Total operating expenses
Loss from operations
Other income, net
Net loss
Other
S-3ASR
ORIC
ORIC Pharmaceuticals Inc
11 Mar 24
Automatic shelf registration
5:28pm
, expected research and development costs, regulatory strategy, timing and likelihood of success, as well as plans and objectives of management for future … the results of the trials will become available, and our research and development programs;
the timing, scope and likelihood of regulatory filings
8-K
EX-99.1
ORIC
ORIC Pharmaceuticals Inc
11 Mar 24
ORIC Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Updates
4:10pm
: Acquired in-process research and development (IPR&D) expenses of $5.0 million for the year ended December 31, 2022, were due to a development milestone … , except share and per share amounts)
Three Months Ended December 31,
Twelve Months Ended December 31,
Operating expenses:
Research and development
8-K
EX-99.1
aws2y5fgiovlm0k11qa5
22 Jan 24
ORIC Pharmaceuticals Announces $125 Million Private Placement Financing
9:01am
8-K
5gj14n dloxbpclvs44
22 Jan 24
ORIC Pharmaceuticals Announces $125 Million Private Placement Financing
9:01am
S-3
gg6e0l n7zdchoowg8
15 Dec 23
Shelf registration
4:32pm
8-K
EX-99.1
xffohqh1
6 Nov 23
ORIC Pharmaceuticals Reports Third Quarter 2023 Financial Results and Operational Updates
4:10pm
8-K
EX-99.1
qg3b 39zr1bopnaud78
10 Aug 23
ORIC Pharmaceuticals Reports Second Quarter 2023 Financial Results and Operational Updates
4:11pm
8-K
EX-99.1
erbisxlpz7usi2hmd4
27 Jun 23
ORIC Pharmaceuticals Announces $85 Million Private Placement Financing
6:05am
8-K
u9dmg1s0xejed 0r8v
27 Jun 23
ORIC Pharmaceuticals Announces $85 Million Private Placement Financing
6:05am
8-K
EX-99.1
y2rv9fvdf91868t 0h
8 May 23
ORIC Pharmaceuticals Reports First Quarter 2023 Financial Results and Operational Updates
4:10pm
424B5
wkio6viyg9 yr1bjxs
21 Dec 22
Prospectus supplement for primary offering
5:23pm
8-K
EX-99.1
c3su2pf3su kvfxl18
7 Nov 22
ORIC Pharmaceuticals Reports Third Quarter 2022
4:10pm